Rare Diseases: Pharma Industry Calls For Collaboration, Political Commitment For Research
Big Pharma wants to develop treatments for rare diseases, with government support. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week launched a new report describing policy priorities to increase research and development into rare diseases.









